Focal Adhesion Kinase-Dependent Role of the Soluble Form of Neurotensin Receptor-3/Sortilin in Colorectal Cancer Cell Dissociation

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2016 Nov 12

PMID 27834811

Citations 12

Authors

Sophie Beraud-Dufour

Chistelle Devader

Fabienne Massa

Morgane Roulot

Thierry Coppola

Jean Mazella

Affiliations

Soon will be listed here.

Abstract

The aim of the present review is to unravel the mechanisms of action of the soluble form of the neurotensin (NT) receptor-3 (NTSR3), also called Sortilin, in numerous physiopathological processes including cancer development, cardiovascular diseases and depression. Sortilin/NTSR3 is a transmembrane protein thought to exert multiple functions both intracellularly and at the level of the plasma membrane. The Sortilin/NTSR3 extracellular domain is released by shedding from all the cells expressing the protein. Although the existence of the soluble form of Sortilin/NTSR3 (sSortilin/NTSR3) has been evidenced for more than 10 years, the studies focusing on the role of this soluble protein at the mechanistic level remain rare. Numerous cancer cells, including colonic cancer cells, express the receptor family of neurotensin (NT), and particularly Sortilin/NTSR3. This review aims to summarize the functional role of sSortilin/NTSR3 characterized in the colonic cancer cell line HT29. This includes mechanisms involving signaling cascades through focal adhesion kinase (FAK), a key pathway leading to the weakening of cell-cell and cell-extracellular matrix adhesions, a series of events which could be responsible for cancer metastasis. Finally, some future approaches targeting the release of sNTSR3 through the inhibition of matrix metalloproteases (MMPs) are suggested.

Citing Articles

Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing.

Demeule M, Currie J, Charfi C, Zgheib A, Cousineau I, Lullier V Front Immunol. 2024; 15:1355945.

PMID: 38482021 PMC: 10936008. DOI: 10.3389/fimmu.2024.1355945.

Neurotensin and Its Involvement in Reproductive Functions: An Exhaustive Review of the Literature.

Arbogast P, Gauchotte G, Mougel R, Morel O, Ziyyat A, Agopiantz M Int J Mol Sci. 2023; 24(5).

PMID: 36902025 PMC: 10002593. DOI: 10.3390/ijms24054594.

Monoclonal Antibody Against Sortilin Induces Apoptosis in Human Breast Cancer Cells.

Simonian M, Haji Ghaffari M, Salimi A, Mirzadegan E, Sadeghi N, Ebrahimnezhad N Avicenna J Med Biotechnol. 2022; 14(1):37-45.

PMID: 35509360 PMC: 9017463. DOI: 10.18502/ajmb.v14i1.8168.

Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer.

Blondy S, Talbot H, Saada S, Christou N, Battu S, Pannequin J J Cell Mol Med. 2020; 25(1):47-60.

PMID: 33325631 PMC: 7810928. DOI: 10.1111/jcmm.15752.

Neurotensin pathway in digestive cancers and clinical applications: an overview.

Christou N, Blondy S, David V, Verdier M, Lalloue F, Jauberteau M Cell Death Dis. 2020; 11(12):1027.

PMID: 33268796 PMC: 7710720. DOI: 10.1038/s41419-020-03245-8.

References

Lefrancois S, Zeng J, Hassan A, Canuel M, Morales C . The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin. EMBO J. 2003; 22(24):6430-7. PMC: 291824. DOI: 10.1093/emboj/cdg629. View

Ogawa K, Ueno T, Iwasaki T, Kujiraoka T, Ishihara M, Kunimoto S . Soluble sortilin is released by activated platelets and its circulating levels are associated with cardiovascular risk factors. Atherosclerosis. 2016; 249:110-5. DOI: 10.1016/j.atherosclerosis.2016.03.041. View

Moody T, Nuche-Berenguer B, Nakamura T, Jensen R . EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer. Curr Drug Targets. 2015; 17(5):520-8. DOI: 10.2174/1389450116666150107153609. View

Willnow T, Petersen C, Nykjaer A . VPS10P-domain receptors - regulators of neuronal viability and function. Nat Rev Neurosci. 2008; 9(12):899-909. DOI: 10.1038/nrn2516. View

Mazella J, Zsurger N, Navarro V, Chabry J, Kaghad M, Caput D . The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J Biol Chem. 1998; 273(41):26273-6. DOI: 10.1074/jbc.273.41.26273. View

Toker A . Phosphoinositide 3-kinases-a historical perspective. Subcell Biochem. 2012; 58:95-110. DOI: 10.1007/978-94-007-3012-0_4. View

Vincent J, Mazella J, Kitabgi P . Neurotensin and neurotensin receptors. Trends Pharmacol Sci. 1999; 20(7):302-9. DOI: 10.1016/s0165-6147(99)01357-7. View

Mitra S, Schlaepfer D . Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol. 2006; 18(5):516-23. DOI: 10.1016/j.ceb.2006.08.011. View

Massa F, Devader C, Lacas-Gervais S, Beraud-Dufour S, Coppola T, Mazella J . Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3. Genes Cancer. 2014; 5(7-8):240-249. PMC: 4162136. DOI: 10.18632/genesandcancer.22. View

10.

Martin S, Vincent J, Mazella J . Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. J Neurosci. 2003; 23(4):1198-205. PMC: 6742286. View

11.

Massa F, Devader C, Beraud-Dufour S, Brau F, Coppola T, Mazella J . Focal adhesion kinase dependent activation of the PI3 kinase pathway by the functional soluble form of neurotensin receptor-3 in HT29 cells. Int J Biochem Cell Biol. 2013; 45(5):952-9. DOI: 10.1016/j.biocel.2013.01.020. View

12.

Martin S, Navarro V, Vincent J, Mazella J . Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. Gastroenterology. 2002; 123(4):1135-43. DOI: 10.1053/gast.2002.36000. View

13.

Temraz S, Mukherji D, Shamseddine A . Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers. Int J Mol Sci. 2015; 16(9):22976-88. PMC: 4613347. DOI: 10.3390/ijms160922976. View

14.

Farhadifar R, Roper J, Aigouy B, Eaton S, Julicher F . The influence of cell mechanics, cell-cell interactions, and proliferation on epithelial packing. Curr Biol. 2007; 17(24):2095-104. DOI: 10.1016/j.cub.2007.11.049. View

15.

Nozue T, Hattori H, Ogawa K, Kujiraoka T, Iwasaki T, Michishita I . Effects of Statin Therapy on Plasma Proprotein Convertase Subtilisin/kexin Type 9 and Sortilin Levels in Statin-Naive Patients with Coronary Artery Disease. J Atheroscler Thromb. 2016; 23(7):848-56. PMC: 7399269. DOI: 10.5551/jat.33407. View

16.

Buttenschon H, Demontis D, Kaas M, Elfving B, Molgaard S, Gustafsen C . Increased serum levels of sortilin are associated with depression and correlated with BDNF and VEGF. Transl Psychiatry. 2015; 5:e677. PMC: 5068760. DOI: 10.1038/tp.2015.167. View

17.

Hermey G . The Vps10p-domain receptor family. Cell Mol Life Sci. 2009; 66(16):2677-89. PMC: 11115710. DOI: 10.1007/s00018-009-0043-1. View

18.

Evron T, Daigle T, Caron M . GRK2: multiple roles beyond G protein-coupled receptor desensitization. Trends Pharmacol Sci. 2012; 33(3):154-64. PMC: 3294176. DOI: 10.1016/j.tips.2011.12.003. View

19.

Stallmach A, Riecken E . [Colorectal carcinoma--current pathogenetic concepts. Significance of cell-matrix interaction for invasive growth and metastasis]. Schweiz Rundsch Med Prax. 1992; 81(26):847-9. View

20.

Green K, Gaudry C . Are desmosomes more than tethers for intermediate filaments?. Nat Rev Mol Cell Biol. 2001; 1(3):208-16. DOI: 10.1038/35043032. View